Christopher Rojao concentrates his practice in complex commercial litigation, with an emphasis on products liability, mass tort, and consumer fraud class action defense.
Chris has extensive experience defending pharmaceutical companies and medical device manufacturers in both state and federal courts. His product liability experience involves defending clients in both single-plaintiff actions as well as in multidistrict litigations (MDL) and multicounty litigations (MCL). Chris also represents commercial clients and manufacturers of consumer products in class actions alleging violations of the New Jersey Consumer Fraud Act, the Telephone Consumer Protection Act and Truth-in-Consumer Contract, Warranty and Notice Act.
In addition to his litigation work, Chris assists in conducting due diligence on behalf of life sciences clients involved in stock and asset purchase transactions. He has also advised clients in FDA regulatory matters, including providing advice for responding to FDA inquiries and interpreting and complying with FDA regulations.
